Cardiology

Early rhythm control key in A-fib and heart failure

(HealthDay)—For patients with atrial fibrillation and signs and symptoms of heart failure, early rhythm control (ERC) therapy reduces cardiovascular events, according to a study published online July 30 in Circulation to ...

Cardiology

Impact of age examined for ticagrelor monotherapy after PCI

(HealthDay)—For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor ...

Psychology & Psychiatry

What stress does to the body and how to beat it

From daily struggles like work pressure to traumatic events like the death of a loved one, everyone has felt some form of stress. People also are experiencing new stressors caused by a global pandemic. Although stress can ...

Psychology & Psychiatry

Stressful life events may up CHD risk in type 2 diabetes

(HealthDay)—Higher levels of stressful life events are associated with a higher risk for coronary heart disease (CHD) among postmenopausal women with type 2 diabetes, according to a study published online June 4 in Diabetes ...

Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Cardiology

Rivaroxaban reduces risk in symptomatic PAD post-intervention

People with symptomatic peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg (lower extremity revascularization) had a 15% reduction ...

page 2 from 18